BIG DATA | “Ouest Datahub”, the first European platform for hospital data, created by GCS HUGO
The first hospital data platform in Europe, Ouest Datahub will group anonymized data from six hospitals engaged in medical research.... View Article
France’s Grand Ouest region, working together to exit the health crisis
Right at the very beginning of the health crisis in March 2020, members of the Atlanpole Biotherapies cluster found themselves... View Article
#Coronavirus | XAV-19 – a national research priority
THE POLYCOR CLINICAL TRIAL HAS BEEN LABELLED A “NATIONAL RESEARCH PRIORITY” The #POLYCOR clinical trial that is currently studying the... View Article
Valneva commences manufacturing of its inactivated, adjuvanted COVID-19 vaccine, completes Phase 1/2 study recruitment
Vaccine production initiated to optimize timeline for potential deliveries Phase 1/2 clinical study now fully enrolled; initial data read out... View Article
New member | Oxy’Pharm
The Oxy’Pharm group wishes to provide its expertise in the field of hygiene by meeting the versatility needs of... View Article
New member | SYMBIOTYC
SYMBIOTYC® provides its customers with more than 20 years of experience in the healthcare industry. It helps pharmaceutical, medical... View Article
KetoM+ | The first product developed
FACILITATING ACCESS TO METABOLIC THERAPEUTIC DIET, HAS DEVELOPED ITS 1ST PRODUCT: A SPECIFIC GROUP FOOD (SGA). It is a formula... View Article
Launch of a healthcare science and innovation partnership between Philips and Rennes University Hopistal that is unique in France
To mark the launch of their science and innovation partnership, Rennes CHU and Philips have spotlighted three major focus... View Article
New member | IRICE
Jeanne Chamousset-Roman is Consultant in Regulatory Affairs and Quality Management in MEDICAL DEVICES supporting companies for various procedures: Regulatory... View Article
Valneva in advanced discussions with European Commission to supply up to 60 million doses of inactivated, adjuvanted COVID-19 vaccine candidate
Valneva, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, today announced it is... View Article